Global Single Cell Genomics Market Forecasts Report 2021-2025 COVID-19 Updates - Study Investigates Immune Hyperactivation
Dublin, April 13, 2021 (GLOBE NEWSWIRE) -- The "Global Single Cell Genomics Market Forecasts by End-user & Technology 2021-2025 with Executive & Consultant Guides, Including Customized Forecasting and Analysis with COVID-19 Updates" report has been added to ResearchAndMarkets.com's offering.
Single Cell Genomics is emerging as a mainstay of scientific research and development. New life forms have already been identified. This means new diseases and new cures.
There are applications in every aspect of healthcare. Just coming out of the lab it is finding its footing in new clinical applications especially related to immune-oncology and microbiology. But the largest market is still in research and the market is booming as understanding the genomics of individual cells opens up a whole new world of biotechnology.
This is a complex area but this readable report will bring the entire management team up to speed, on both the technology and the opportunity.
The technology is moving faster than the market. Genomics and Immunology are playing a role too. Find the opportunities and the pitfalls. Understand growth expectations and the ultimate potential market size.
Key Topics Covered:
1. Introduction and Market Definition
1.1 What is Single Cell Genomics?
1.2 SCG - Still Early Days
1.3 Market Definition
1.3.1 Market Size
1.3.2 Currency
1.3.3 Years
1.4 Methodology
1.5 Sizing the Genome - Not What You Think
1.5.1 Cost, Price and Genome Size, Pricing Practice
1.6 Global Listing of High Throughput Sequencing Establishments Installed Base - Location & Contacts
2. Single Cell Genomics - Guide to Technology
2.1 Isolating Single Cells
2.1.1 FACS
2.1.2 LCM
2.1.3 Micromanipulators
2.1.4 Microfluidics
2.2 Amplification
2.2.1 WTA - Whole Transcriptome Amplification
2.2.2 WGA - Whole Genome Amplification
2.3 PCR
2.4 NGS
2.5 Microarray
2.6 Digital Spatial Profiling (DSP) Technology
3. Industry Overview
3.1 Players in a Dynamic Market
3.1.1 Academic Research Lab
3.1.2 Genomic Instrumentation Supplier
3.1.3 Cell Separation and Viewing Instrumentation Supplier
3.1.4 Cell Line and Reagent Supplier
3.1.5 Pharmaceutical or Reagent Company
3.1.6 Audit Body
3.1.7 Certification Body
4. Market Trends
4.1 Factors Driving Growth
4.1.1 Immuno-oncology
4.1.2 Research Range
4.1.3 Technology Maturity & Convergence
4.1.4 Declining Costs
4.2 Factors Limiting Growth
4.2.1 Competition
4.2.2 Instrument Integration
4.2.3 Technology Shift
4.2.4 Technology Limitations
4.3 Technology Development
4.3.1 Spatial Profiling
4.3.2 Integration
4.3.3 Big Data
4.3.4 Kits and Commodities
5. Single Cell Genomics Recent Developments
5.1 Recent Developments - Importance and How to Use This Section
5.1.1 Importance of These Developments
5.1.2 How to Use This Section
Parse Biosciences Lowers Cost Barriers to Single-Cell Transcriptomics
Deepcell Advancing Tech for Single-Cell Genomics
10x Genomics Outlines 2021 Growth Plans
Single-Cell Genomics Firm Analytical Biosciences Inks Deal with BioMap
IsoPlexis Features Cheaper, More Flexible Single-Cell Proteomic Systems
DNTR-Seq Combines WGS, Transcriptomics in Single Cells
BitBiome Builds Single-Cell Bacterial Sequencing Business
S2 Genomics Signs Distribution Agreements for Asia-Pacific
Single-Cell COVID-19 Study Investigates Immune Hyperactivation
Levitas Bio to Launch Magnetic Levitation Cell Separation Platform
Single-Cell and Spatial Genomics
Single-Cell Genomics
Namocell, Takara Bio, HepaTx Partner on Single-Cell Genomics
Vizgen Launches With $14M Series A Financing
SeqWell Raises $9M in Series B Round
MGI Tech Introduces Portable Sequencer, Single-Cell Prep Device
Celsius Therapeutics to Use Single-Cell Platform in Immuno-Oncology
10x Genomics Expects $271M In Proceeds
Celsius Therapeutics, Janssen Biotech Form Biomarker Discovery Alliance
Bio-Rad, 10x Genomics Claim Single-Cell Patent Fight Victories on Different Fronts
Bio-Rad Launches its Single Cell scATAC-Seq Solution
10x Genomics Acquires Spatial Transcriptomics
Takara Bio strengthens its IP position on single cell RNA-seq
Mission Bio Launches Tapestri for Targeted Single-Cell DNA Custom Panels
SingulOmics Detects Somatic Single Nucleotide Variations in Single Cells
1CELLBIO and OMI to validate Single Cell Analysis for Personalized Medicine
Sony MA900 Cell Sorter Nominated
UNC Cure Center and Cell Microsystems Receive NIH Contract for Single Cell HIV
Diagnostic Assay
Bio-Rad's dd-PCR tests for leukemia cleared
IncellDx's Single Cell Immuno-Oncology/PD-L1 Technology used in new Cancer Assay
Cytena GmbH land EUR 3M in Series A
NanoString Announces Launch of CAR-T Panel
Dolomite Bio launches high throughput single nuclei profiling on Nadia platform
Silicon Biosystems Develops New Assay for Circulating Multiple Myeloma Cells
6. Profiles of Key Single Cell Genomics Companies
10x Genomics
1CellBio
Agilent
Beckman Coulter
Becton Dickinson
Bio-Rad
Bitbiome
Bruker
Cell Microsystems
Cellsee Diagnostics
CellSorter
Cytena
CytoTrack
Dolomite Bio
Fluidigm
Fluxion Biosciences
Illumina
IncellDx
Labcyte
Leica Microsystems
Miltenyi Biotec
Mission Bio
Oxford Nanopore Technologies
NanoString
Perkin Elmer
Qiagen
Readcoor
S2 Genomics
Silicon Biosystems
Singulomics
Sony
Takara Bio
Thermo Fisher
Watchmaker Genomics
7. Single Cell Genomics Global Market Size
7.1 Global Market Overview by Country
7.2 Global Market Size by Technology - Overview
7.3 Global Market End-user - Overview
8. Global Market by Technology
8.1 PCR Market
8.2 qPCR Market
8.3 NGS Market
8.4 Microarray Market
8.5 Other Technology Market
9. Single Cell Genomics Market by End-user
9.1 Research Market
9.2 BioPharma Market
9.3 Clinical Market
9.4 Other End-user Market
10. Appendices
10.1 FDA Cancer Drug Approvals by Year
10.2 Clinical Trials Started 2010 to 2016
10.3 Prevalence of Cancer Treatments
For more information about this report visit https://www.researchandmarkets.com/r/5de2si
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900